• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过非天然氨基酸取代增强抗菌肽抗癌活性及诱导免疫原性细胞死亡的策略

Strategy to Enhance Anticancer Activity and Induced Immunogenic Cell Death of Antimicrobial Peptides by Using Non-Nature Amino Acid Substitutions.

作者信息

Cheah Yu-Huan, Liu Chun-Yu, Yip Bak-Sau, Wu Chih-Lung, Peng Kuang-Li, Cheng Jya-Wei

机构信息

Department of Medical Science, Institute of Biotechnology, National Tsing Hua University, Hsinchu 300, Taiwan.

Department of Neurology, National Taiwan University Hospital Hsinchu Branch, Hsinchu 300, Taiwan.

出版信息

Biomedicines. 2022 May 9;10(5):1097. doi: 10.3390/biomedicines10051097.

DOI:10.3390/biomedicines10051097
PMID:35625834
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9138567/
Abstract

There is an urgent and imminent need to develop new agents to fight against cancer. In addition to the antimicrobial and anti-inflammatory activities, many antimicrobial peptides can bind to and lyse cancer cells. P-113, a 12-amino acid clinically active histatin-rich peptide, was found to possess anti- activities but showed poor anticancer activity. Herein, anticancer activities and induced immunogenic cancer cell death of phenylalanine-(Phe-P-113), β-naphthylalanine-(Nal-P-113), β-diphenylalanine-(Dip-P-113), and β-(4,4'-biphenyl)alanine-(Bip-P-113) substituted P-113 were studied. Among these peptides, Nal-P-113 demonstrated the best anticancer activity and caused cancer cells to release potent danger-associated molecular patterns (DAMPs), such as reactive oxygen species (ROS), cytochrome c, ATP, and high-mobility group box 1 (HMGB1). These results could help in developing antimicrobial peptides with better anticancer activity and induced immunogenic cell death in therapeutic applications.

摘要

迫切需要开发新的抗癌药物。除了具有抗菌和抗炎活性外,许多抗菌肽还能与癌细胞结合并使其裂解。P-113是一种含12个氨基酸且富含组蛋白的具有临床活性的肽,已发现它具有抗……活性,但抗癌活性较差。在此,研究了苯丙氨酸取代的P-113(Phe-P-113)、β-萘丙氨酸取代的P-113(Nal-P-113)、β-二苯丙氨酸取代的P-113(Dip-P-113)和β-(4,4'-联苯)丙氨酸取代的P-113(Bip-P-113)的抗癌活性及诱导的免疫原性癌细胞死亡。在这些肽中,Nal-P-113表现出最佳的抗癌活性,并使癌细胞释放出强效的危险相关分子模式(DAMPs),如活性氧(ROS)、细胞色素c、三磷酸腺苷(ATP)和高迁移率族蛋白B1(HMGB1)。这些结果有助于在治疗应用中开发具有更好抗癌活性和诱导免疫原性细胞死亡的抗菌肽。

相似文献

1
Strategy to Enhance Anticancer Activity and Induced Immunogenic Cell Death of Antimicrobial Peptides by Using Non-Nature Amino Acid Substitutions.通过非天然氨基酸取代增强抗菌肽抗癌活性及诱导免疫原性细胞死亡的策略
Biomedicines. 2022 May 9;10(5):1097. doi: 10.3390/biomedicines10051097.
2
Dependence on size and shape of non-nature amino acids in the enhancement of lipopolysaccharide (LPS) neutralizing activities of antimicrobial peptides.依赖于非天然氨基酸的大小和形状来增强抗菌肽对脂多糖(LPS)的中和活性。
J Colloid Interface Sci. 2019 Jan 1;533:492-502. doi: 10.1016/j.jcis.2018.08.042. Epub 2018 Aug 14.
3
Selective phenylalanine to proline substitution for improved antimicrobial and anticancer activities of peptides designed on phenylalanine heptad repeat.选择性苯丙氨酸至脯氨酸取代以改善基于苯丙氨酸七肽重复序列设计的肽的抗菌和抗癌活性。
Acta Biomater. 2017 Jul 15;57:170-186. doi: 10.1016/j.actbio.2017.05.007. Epub 2017 May 5.
4
Boosting Synergistic Effects of Short Antimicrobial Peptides With Conventional Antibiotics Against Resistant Bacteria.增强短抗菌肽与传统抗生素对耐药菌的协同作用。
Front Microbiol. 2021 Oct 18;12:747760. doi: 10.3389/fmicb.2021.747760. eCollection 2021.
5
Role of β-naphthylalanine end-tags in the enhancement of antiendotoxin activities: Solution structure of the antimicrobial peptide S1-Nal-Nal in complex with lipopolysaccharide.β-萘丙氨酸末端标签在增强抗内毒素活性中的作用:抗菌肽 S1-Nal-Nal 与脂多糖复合物的溶液结构。
Biochim Biophys Acta Biomembr. 2017 Jun;1859(6):1114-1123. doi: 10.1016/j.bbamem.2017.03.007. Epub 2017 Mar 10.
6
Antimicrobial Peptides Display Strong Synergy with Vancomycin Against Vancomycin-Resistant , , and Wild-Type .抗菌肽与万古霉素联用对耐万古霉素、肠球菌和野生型肠球菌显示出强大的协同作用。
Int J Mol Sci. 2020 Jun 27;21(13):4578. doi: 10.3390/ijms21134578.
7
Easy strategy to increase salt resistance of antimicrobial peptides.提高抗菌肽耐盐性的简易策略。
Antimicrob Agents Chemother. 2011 Oct;55(10):4918-21. doi: 10.1128/AAC.00202-11. Epub 2011 Jul 18.
8
Preventive effects of the novel antimicrobial peptide Nal-P-113 in a rat Periodontitis model by limiting the growth of Porphyromonas gingivalis and modulating IL-1β and TNF-α production.新型抗菌肽Nal-P-113通过限制牙龈卟啉单胞菌的生长以及调节白细胞介素-1β和肿瘤坏死因子-α的产生,对大鼠牙周炎模型具有预防作用。
BMC Complement Altern Med. 2017 Aug 29;17(1):426. doi: 10.1186/s12906-017-1931-9.
9
Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immunogenic cell death in pancreatic cancer.分支溶瘤肽靶向硫酸乙酰肝素蛋白聚糖,抑制转移,并触发胰腺癌中免疫原性细胞死亡分子决定因素的释放。
Front Mol Biosci. 2024 Oct 2;11:1429163. doi: 10.3389/fmolb.2024.1429163. eCollection 2024.
10
Colon Cancer Cells Treated with Lacticaseibacillus casei Undergo Apoptosis and Release DAMPs Indicative of Immunogenic Cell Death.经干酪乳杆菌处理的结肠癌细胞会发生凋亡并释放表明免疫原性细胞死亡的损伤相关分子模式。
Probiotics Antimicrob Proteins. 2024 Sep 16. doi: 10.1007/s12602-024-10330-3.

引用本文的文献

1
Hydrogels in cancer treatment: mapping the future of precision drug delivery.水凝胶在癌症治疗中的应用:绘制精准药物递送的未来蓝图。
Front Immunol. 2025 Jul 8;16:1607240. doi: 10.3389/fimmu.2025.1607240. eCollection 2025.
2
Cationic antimicrobial peptides: potential templates for anticancer agents.阳离子抗菌肽:抗癌药物的潜在模板。
Front Med (Lausanne). 2025 Apr 24;12:1548603. doi: 10.3389/fmed.2025.1548603. eCollection 2025.
3
Antimicrobial peptides as drugs with double response against coinfections in lung cancer.抗菌肽作为对肺癌合并感染具有双重反应的药物。

本文引用的文献

1
PKHB1, a thrombospondin-1 peptide mimic, induces anti-tumor effect through immunogenic cell death induction in breast cancer cells.PKHB1,一种血小板反应蛋白-1 肽模拟物,通过诱导乳腺癌细胞免疫原性细胞死亡发挥抗肿瘤作用。
Oncoimmunology. 2022 Apr 4;11(1):2054305. doi: 10.1080/2162402X.2022.2054305. eCollection 2022.
2
Antimicrobial peptides, conventional antibiotics, and their synergistic utility for the treatment of drug-resistant infections.抗菌肽、传统抗生素及其在治疗耐药性感染中的协同作用。
Med Res Rev. 2022 Jul;42(4):1377-1422. doi: 10.1002/med.21879. Epub 2022 Jan 4.
3
Multifunctional Antibiotic-Host Defense Peptide Conjugate Kills Bacteria, Eradicates Biofilms, and Modulates the Innate Immune Response.
Front Microbiol. 2023 Jun 2;14:1183247. doi: 10.3389/fmicb.2023.1183247. eCollection 2023.
4
A Thermodynamic Study on the Interaction between RH-23 Peptide and DMPC-Based Biomembrane Models.RH-23肽与基于二肉豆蔻酰磷脂酰胆碱的生物膜模型相互作用的热力学研究
Membranes (Basel). 2022 Dec 19;12(12):1282. doi: 10.3390/membranes12121282.
多功能抗生素-宿主防御肽缀合物可杀死细菌、根除生物膜并调节先天免疫反应。
J Med Chem. 2021 Nov 25;64(22):16854-16863. doi: 10.1021/acs.jmedchem.1c01712. Epub 2021 Nov 16.
4
Boosting Synergistic Effects of Short Antimicrobial Peptides With Conventional Antibiotics Against Resistant Bacteria.增强短抗菌肽与传统抗生素对耐药菌的协同作用。
Front Microbiol. 2021 Oct 18;12:747760. doi: 10.3389/fmicb.2021.747760. eCollection 2021.
5
Membrane-disruptive peptides/peptidomimetics-based therapeutics: Promising systems to combat bacteria and cancer in the drug-resistant era.基于膜破坏肽/肽模拟物的疗法:在耐药时代对抗细菌和癌症的有前景的系统。
Acta Pharm Sin B. 2021 Sep;11(9):2609-2644. doi: 10.1016/j.apsb.2021.07.014. Epub 2021 Jul 21.
6
Biomedical Relevance of Novel Anticancer Peptides in the Sensitive Treatment of Cancer.新型抗癌肽在癌症敏感治疗中的生物医学相关性。
Biomolecules. 2021 Jul 29;11(8):1120. doi: 10.3390/biom11081120.
7
Antibiofilm activity of host defence peptides: complexity provides opportunities.宿主防御肽的抗生物膜活性:复杂性提供了机会。
Nat Rev Microbiol. 2021 Dec;19(12):786-797. doi: 10.1038/s41579-021-00585-w. Epub 2021 Jun 28.
8
Chemically modified and conjugated antimicrobial peptides against superbugs.化学修饰和缀合的抗菌肽对抗超级细菌。
Chem Soc Rev. 2021 Apr 26;50(8):4932-4973. doi: 10.1039/d0cs01026j.
9
Marine Antimicrobial Peptide TP4 Exerts Anticancer Effects on Human Synovial Sarcoma Cells via Calcium Overload, Reactive Oxygen Species Production and Mitochondrial Hyperpolarization.海洋抗菌肽 TP4 通过钙超载、活性氧产生和线粒体超极化对人滑膜肉瘤细胞发挥抗癌作用。
Mar Drugs. 2021 Feb 5;19(2):93. doi: 10.3390/md19020093.
10
Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors.在一项剂量递增的 I 期临床试验中评估溶瘤肽 LTX-315 在实体瘤患者中的安全性、抗肿瘤活性和 T 细胞应答。
Clin Cancer Res. 2021 May 15;27(10):2755-2763. doi: 10.1158/1078-0432.CCR-20-3435. Epub 2021 Feb 4.